Jason De Meese

Title: Jason De Meese: Innovator in Pharmaceutical Compounds

Introduction

Jason De Meese is a notable inventor based in Firestone, Colorado. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific kinases involved in various disorders. With a total of 3 patents, his work has the potential to impact the treatment of numerous medical conditions.

Latest Patents

One of Jason's latest patents involves Pyrazole [3, 4-B] pyridine Raf inhibitors. These compounds are useful for the inhibition of Raf kinases. The patent discloses methods for using these compounds, including their stereoisomers, tautomers, prodrugs, and pharmaceutically acceptable salts, for in vitro, in situ, and in vivo diagnosis, prevention, or treatment of disorders in mammalian cells. Another significant patent focuses on heterobicyclic thiophene compounds. These compounds and their pharmaceutically acceptable salts are designed to inhibit receptor tyrosine kinases, providing methods for the diagnosis, prevention, or treatment of related disorders.

Career Highlights

Throughout his career, Jason has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Array Biopharma Inc. and Genentech, Inc. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Jason has collaborated with several talented individuals in his field, including Jeongbeob Seo and Hongqi Tian. These partnerships have likely enhanced his research and development efforts, leading to the successful creation of his patented compounds.

Conclusion

Jason De Meese is a distinguished inventor whose work in pharmaceutical compounds showcases his commitment to advancing medical science. His patents reflect a deep understanding of complex biological processes and a dedication to improving patient outcomes.